Induction of Immunologic Tolerance for Allogeneic Hematopoietic Cell Transplantation

References

• Appelbaum. ER. (20011 "Hnematopoietic cell transplantation as nil mu nothera py". Milner 411, 385–589.
   Google Scholar
• Barnes, D.W.H., Corp, MJ., Louth, LE and Neal, F.E. (1956) "Treatment of inurine leukemia with X-rays and homologous bone marrow. Preliminary cuminunication". 81: Med. .1 2, 626–627,
   Google Scholar
• Weiden, P.L. (1979) "Antileukernic effects of graft-versus-host disease in human recipients of allogeneie marrow grafts", N. Engl. _II Med. 300, 1068-1.073.
   Google Scholar
• Weiden, P.L., Sullivan. K.M., Flournoy. N.. Storb. R. arid Thomas. E.D. Seattle Marrow Transplant Team (1981) "Antileukemic effect of chronic gull-versus-host disease. Cnntribution to improved survival after allogeneic marrow transplantation". N. EngI. I. Med. 304, 152–l531.
   Google Scholar
• Horowitz. MM. f1990) "araft-versus-ieultemin reactions after hone marrow transplantation". Wood 1990, 555–562.
   Google Scholar
• Kolb, H.J. (1995) "G raft- versus-leukemi a effect of donor lymphocyte transfusions in marrow grafted patients. European group for blood and marrow transplantation working party chronic leukemia", Blood 86, 2a41–2050.
   Google Scholar
• Doyle, C and Strominger. J.L. (1987) Interaction between CD4 and class TI WIC molecule mediates cell adhesion", Nature 330. 256–259.
   Google Scholar
• Nortnent, AAA., Salter, R.D., Parham. P., Engelhard, VII. and Littman. DR. (1988) "Cell-cell adhesion mediated by CDR and WIC class I molecules". Nature 336, 79–81.
   PubMed Web of Science ®Google Scholar
• Bother. J.G. (1999) "Nomenclature fur factors of the HLA system. 1998". Male Antigens 53, 407–446.
   Google Scholar
• Parham, P. (1992) "Decnnstructing the MHC". Nature 360, 300 301.
   PubMed Web of Science ®Google Scholar
• Ferrara. J.L.M. raid Deeg, H.J. (1991) "Mechanisms of disease. Graft•versus-host disease". N. Engl. J. Med, 324, 667–674.
   PubMed Web of Science ®Google Scholar
• Nash, R.A,11992) "Acute graft-versus-host disease: analysis of risk factors after allogencie marrow transplantation and prophylaxis with cyclosporin and rnethotrexate. Blood 80, 1838–1845.
   PubMed Web of Science ®Google Scholar
• Petersdorf. E.W. (1998) "Optimizing outcome after unrelated marrow transplantation by comprehensive matching uf HLA class] and II alleles in the donor and recipient", mood 89. 1818–1823.
   Google Scholar
• Petersdorf. E.W. (1997) "Association of HLA-C display with graft failure after marrow transplantation form unrelated donors". Blood 89, 1818–1823.
   PubMed Web of Science ®Google Scholar
• Papadopoulos. E.B. (1998) "T cell-depleted allogeneic bone marrow transplantation as pa remission therapy for acute myelogcnous leukemia: freedom from relapse in the absence of graft-versus host disease". Blood 91, 1083–1090.
   PubMed Web of Science ®Google Scholar
• Storek. J. and Storb. R. (2000)"!' cell reconstitution after stem-cell transplantation-by which organ?". Lancet 355, 1843–1844.
   PubMed Web of Science ®Google Scholar
• Soifer, R., Murray, C., Gortin, R. and Ritz, .L(1994) "Effect ot low-dose interleukin-2 on disease relapse after T cell depleted allogeneie bone marrow transplantation". Blood 84, 964–971.
   Google Scholar
• Drazi. F. (2000) "Comparison of single-dose and escalating dose regimens of donor lympliucyte infusion for relapse after allogralling for chronic myeloid leukemia". Blood 95, 67.–71.
   PubMed Web of Science ®Google Scholar
• Boussiotic, V.A.. Gribben. J.G., Freeman, GJ. and Nadler. L.M. (1994) "Blockade of the C1)28 costimulatury pathway: a means to induce tolerance". Cure. Opin. hnnmnol. 6„ 797 807.
   Google Scholar
• Schwartz, R.H. (1997)"1cell clonal energy", Cure Opiti. Mimeo:L.1, 9,351–357.
   Google Scholar
• Blazer. BR.. Korngold, R. and Vallera. D.A. (1997) "Recent advances in graft-versus-host disease prevention". fitormnoL Reu 157, 79–109.
   Google Scholar
• Boussiotis, V.A., Freeman, G.1.. Gribben, J.G. and Nadler, L.M. (1996) "The role of B7-11.137-2:CD28/CTLA-4 pathways in the prevention of energy, induction of productive immunity and down-regulation of the immune response". lmmuanjl. Rem 153, 5–26.
   Google Scholar
• Gueider, S.. Meyerhnff, J. and Haveil. R. (1994) "The role of the T cell costimulator B7-1 in autuunmunity and the induction and maintenance of tolerance to peripheral antigen". Lannindry 1. 155–166.
   Google Scholar
• Twice, LA.. Linsley, P.S., Lin, H.. Brady, W.. Leiden. 1.M.. Wei. R.Q., Gibson. MI.,. Meng, X.G., Myrdal, S.. Gordon, D., T.. Bolling, S.F. and Thompson. C.B. (1992) "T ecU activation by the CD28 ligand B7 is required fur cardiac allograll rejection in vivo". Pear. Nod Arad. Sri, USA 89. 11102–11105.
   PubMed Web of Science ®Google Scholar
• Sun, H., Subbotin. V., Chen, C.. A.A., Valdivia. L.A., Sayeg,h. M.H.. Linsley. P.S., Fung, IJ., Starzl, T.E. and Rao, A.S. (1997) "Prevention of chronic rejection in mouse aortic altografts by combined treatment with CTLA1-Ig and anri-CD40 ligand monoclonal antibody", Thunsplantotion 64. 1838–1843.
   PubMed Web of Science ®Google Scholar
• Kirk. A.D., Harlan, D.M., Armstrong. N.N., Davis, T.A.., Dong, Gray, G.S.. Hong. X., Thomas, D.. Fechner. LIU, and Xnechtle. Si. (1997)"CTLA4.1g and anti-CD40 ligand prevent renal allograft rejection in primates". Proc. Nall Acad. Sci. 94. 8789–8794.
   PubMed Web of Science ®Google Scholar
• Isiazar.B.R.. Taylor, P.A., Linsley. P.S. and Valium, P.A. (1994) "hi vivo blockade of CD28/CTLA4:07/BB I interaction with C1'LA4-Ig reduces lethal murine graft-versus-host disease BCIT, the major histocoinpatibility complex barrier in mice". Blood 83, 3815 3825, 124]
   Google Scholar
• Teller. J.C.. Panoskaltsis-Mortari. A., Murphy. W.I., Ruscetti, Namla, S... Roncorolo. M.G. and Blazar, R.R. (1499) "Induction of CD44 T cell alluatillgen•sperific hyporesponsiveness by IL-10 and TGF-13", 3. Inonitnol. 163, 3684–3691.
   Google Scholar
• Boussiotis. VA., Chen, Z.-M.. Zeller, J.C.. Murphy, WI-Berezovskaya. A., Nurula, S., Roncarolo, M.G. and Blazar, B.R. (200T) "Altered T cell receptor + CD28-mediated signaling and blocked cell cycle progression in intcrleukin 10 and transforming growth factor-b-treated allnreactive T cells that du not induce graft-versus-host diwose- Blood IS. 565-57I.
   Google Scholar
• Krenger, W.. Hill. G.R. and Ferrara. J.L. (1997) "Cytokine cascades in acute graft-versus-Itost disease". Transplantation 64, 553–558.
   Google Scholar
• Shlomchik, W.D. (1999) "Prevention of graft versus host disease by inactivation of host antigen-presenting cells". Science 235, 412–415.
   Web of Science ®Google Scholar
• Tzachanis. D., Berezovskaya, A_ Nadler, LM. and Ftoussiotis. (201301 "Blockade of B71CD28 pathway in MLR cultures results in the generation of alternatively activated macrophages. which suppress T cell responses". Blood.
   Google Scholar
• Fry, D.W., Bedford, D.C.. Harvey, PH., Fri tch, A., Keller. P.R.. Wu, Z., Dobrusin. E., Leopold. W.R., Fattaey. A. and Garrett, M.D. (2001) "Cell cycle and biochemical effects of PD 0183812". J. Mot Chem_ 276. 16617–16623.
   Google Scholar
• Li, Y., Zheng, X.X., Li. X.C.. Zand. M.S. and Strom, T.B. (1998) "Combined costimulation blockade plus rapamycin but not cyclusporin produces permanent cagraftinent", Transpiankuion 66, 1387–1388.
   Google Scholar